| Product Code: ETC4877031 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Nuclear Medicine Radioisotopes Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Latvia Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine procedures |
4.2.2 Advancements in nuclear medicine technology and procedures |
4.2.3 Growing awareness about the benefits of nuclear medicine in diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the use and handling of radioisotopes |
4.3.2 High initial setup and operational costs of nuclear medicine facilities |
4.3.3 Limited availability of skilled professionals in the field of nuclear medicine |
5 Latvia Nuclear Medicine Radioisotopes Market Trends |
6 Latvia Nuclear Medicine Radioisotopes Market Segmentations |
6.1 Latvia Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021-2031F |
6.1.3 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021-2031F |
6.1.4 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021-2031F |
6.1.5 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021-2031F |
6.1.6 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021-2031F |
6.1.7 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021-2031F |
6.1.9 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.2 Latvia Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021-2031F |
6.2.4 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021-2031F |
6.2.5 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021-2031F |
6.2.6 Latvia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
7 Latvia Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Latvia Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Latvia Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Latvia Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Average number of nuclear medicine procedures conducted per month/year |
8.2 Percentage increase in the adoption of new radioisotopes in medical facilities |
8.3 Average waiting time for patients to undergo nuclear medicine procedures |
8.4 Number of research and development projects focusing on nuclear medicine technologies |
8.5 Percentage of healthcare professionals attending nuclear medicine training programs |
9 Latvia Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Latvia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Latvia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Latvia Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024 |
10.2 Latvia Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here